By Nancy Lapid July 9 (Reuters) - A biotechnology company says it has successfully used its 3D bioprinter aboard the ...

Highly sensitive next-generation sequencing-based MRD testing will identify eligible patients with T-cell malignancies ...

Parabilis Medicines is ambitious, but it has Regeneron on its side already.

Analysts have given Alnylam Pharmaceuticals an average price target of $436.

Biotech stock Arcutis is in a buy zone and Wall Street is looking for the skin-diseases drugmaker to expand the use of its ...

Dr Reddy's Laboratories will halt semaglutide injection supplies until at least October. Unspecified impurities were ...

Healthcare veteran Dr Douglas Williams discusses the impact of recent political upheaval in the US and the prospect of major ...

Three biotech companies are slated to move into the former athenahealth headquarters in Watertown, which was sold it to life sciences developer Alexandria for $525.5 million.

Researchers at the University of Bayreuth and Forschungszentrum Jülich have demonstrated that specific light-sensitive ...

Diagnostics specialist Beckman Coulter has expanded its portfolio of Alzheimer’s disease diagnostics by earning a ...

At an event for pharmaceutical executives, biotech founders, and researchers on Tuesday, Anthropic announced Claude Science, ...

Women in England are set to gain new, taxpayer-funded tests for endometriosis after NICE recommended them for regular use. | ...